Search Results 51-60 of 16279 for CLL

  1. Acute lymphocytic leukemia - Symptoms and causes - Mayo Clinic

    Learn about this cancer that forms in the blood and bone marrow. Treatments include medications and bone marrow transplant.

  2. Analysis of Immunostaining during Mohs Micrographic Surgery to Improve Detection of Negative Surgical Margins in Patients with Squamous Cell Carcinoma and Chronic Lymphocytic Leukemia (CLL)/ Non-Hodgkins Lymphoma (NHL) - Mayo Clinic

    ... Chronic Lymphocytic Leukemia (CLL)/ Non-Hodgkins Lymphoma (NHL). Print ... chronic lymphocytic leukemia (CLL)/non-Hodgkin lymphoma (NHL). The study will ...

  3. Ibrutinib (oral route) - Mayo Clinic

    Description. Ibrutinib is used to treat chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), chronic lymphocytic leukemia (CLL)/small ...

  4. A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia - Mayo Clinic

    ... chronic lymphocytic leukemia (CLL). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...

  5. Fludarabine (oral route) - Mayo Clinic

    It is used to treat a type of cancer of the white blood cells called B-cell chronic lymphocytic leukemia (CLL). This medicine is used in patients with CLL ...

  6. Family Study of Monoclonal B-Cell Lymphocytosis (MBL) - Mayo Clinic

    Given that family members of CLL patients are known to have an increased risk of CLL (on the order of 8-fold), and they have a higher prevalence of MBL than in ...

  7. Zanubrutinib (oral route) - Mayo Clinic

    This medicine is also used to treat chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Zanubrutinib is also used in combination with ...

  8. Clinical trials - Oncology (Medical)

    The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) or Small ...

  9. Neil E. Kay, M.D. - Mayo Clinic Faculty Profiles

    The laboratory research of Neil E. Kay, M.D., is focused on B-chronic lymphocytic leukemia (CLL). This most common and still incurable leukemia is not fully ...

  10. Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas - Mayo Clinic

    Giving pembrolizumab alone or with idelalisib or ibrutinib may be an effective treatment in patients with chronic lymphocytic leukemia or other low-grade B-cell ...